Novavax Inc. closed 74.96% below its 52-week high of $23.86, which the company reached on June 6th.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Stoke Therapeutics (STOK – Research Report), Novavax (NVAX – Research Report) ...

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

US$666.7m (up by US$572.8m from ...